Haisco Pharmaceutical Group Co Debt 2024

Haisco Pharmaceutical Group Co Debt

650.31 CNY

Haisco Pharmaceutical Group Co Dividend yield

0.59 %

Ticker

002653.SZ

ISIN

CNE100001BC7

In 2024, Haisco Pharmaceutical Group Co's total debt was 650.31 CNY, a -51.8% change from the 1,349.18 CNY total debt recorded in the previous year.

Haisco Pharmaceutical Group Co Aktienanalyse

What does Haisco Pharmaceutical Group Co do?

Haisco Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Haisco Pharmaceutical Group Co's Debt Structure

Haisco Pharmaceutical Group Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Haisco Pharmaceutical Group Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Haisco Pharmaceutical Group Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Haisco Pharmaceutical Group Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Haisco Pharmaceutical Group Co Stock

What is the debt of Haisco Pharmaceutical Group Co this year?

Haisco Pharmaceutical Group Co has a debt level of 650.31 CNY this year.

What was the debt of Haisco Pharmaceutical Group Co compared to the previous year?

The debt of Haisco Pharmaceutical Group Co has increased by -51.8% compared to the previous year dropped.

What are the consequences of high debt for investors in Haisco Pharmaceutical Group Co?

High debt can pose a risk for investors of Haisco Pharmaceutical Group Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Haisco Pharmaceutical Group Co?

Low debt means that Haisco Pharmaceutical Group Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Haisco Pharmaceutical Group Co affect the company?

An increase in debt of Haisco Pharmaceutical Group Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Haisco Pharmaceutical Group Co affect the company?

A reduction in debt of Haisco Pharmaceutical Group Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Haisco Pharmaceutical Group Co?

Some factors that can influence the debt of Haisco Pharmaceutical Group Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Haisco Pharmaceutical Group Co so important for investors?

The debts of Haisco Pharmaceutical Group Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Haisco Pharmaceutical Group Co take to change the debt?

To change the debt, Haisco Pharmaceutical Group Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Haisco Pharmaceutical Group Co pay?

Over the past 12 months, Haisco Pharmaceutical Group Co paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 0.59 %. For the coming 12 months, Haisco Pharmaceutical Group Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Haisco Pharmaceutical Group Co?

The current dividend yield of Haisco Pharmaceutical Group Co is 0.59 %.

When does Haisco Pharmaceutical Group Co pay dividends?

Haisco Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of June, August, May, August.

How secure is the dividend of Haisco Pharmaceutical Group Co?

Haisco Pharmaceutical Group Co paid dividends every year for the past 3 years.

What is the dividend of Haisco Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Haisco Pharmaceutical Group Co located?

Haisco Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Haisco Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Haisco Pharmaceutical Group Co from 7/5/2022 amounting to 0.185 CNY, you needed to have the stock in your portfolio before the ex-date on 7/5/2022.

When did Haisco Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 7/5/2022.

What was the dividend of Haisco Pharmaceutical Group Co in the year 2023?

In the year 2023, Haisco Pharmaceutical Group Co distributed 0.185 CNY as dividends.

In which currency does Haisco Pharmaceutical Group Co pay out the dividend?

The dividends of Haisco Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Haisco Pharmaceutical Group Co

Our stock analysis for Haisco Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Haisco Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.